- Allogeneic vaccination with a B7.1 HLA-A gene-modified adenocarcinoma cell line in patients with advanced non-small-cell lung cancer. Raez, L.E., Cassileth, P.A., Schlesselman, J.J., Sridhar, K., Padmanabhan, S., Fisher, E.Z., Baldie, P.A., Podack, E.R. J. Clin. Oncol. (2004)